Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his abdomen after drinking water. It was just a fleeting moment; one he brushed ...

Outcomes of patients following dose-dense neoadjuvant chemotherapy for muscle-invasive bladder cancer: Implications for organ-sparing strategies. Avelumab treatment in metastatic urothelial carcinoma: ...

Investigators hypothesize that patients presented later to their health care providers during the first year of the pandemic. Investigators in Ireland report that the rate of more advanced and more ...

As part of its “Speaking Out” video series, CURE spoke with Dr. Tracy L. Rose, on behalf of the Bladder Cancer Advocacy Network, about how currently available agents are being investigated in ...

BAY COUNTY, Fla. (WMBB) – Bay County’s Advanced Urology Institute is being recognized as a center of excellence for treating ...

Case series and cohort studies suggest hypofractionated radiotherapy (55 Gy/20 fractions) offers similar response, survival, and toxicity to conventional radiotherapy (64 Gy/32 fractions), but ...

Petros Grivas, MD, PhD, reviews data from recent subgroup analyses for the JAVELIN Bladder 100 study for advanced urothelial carcinoma from the 2021 ASCO GU Virtual Symposium. Petros Grivas, MD, PhD: ...

The medication is being tested as adjuvant therapy in patients with locally advanced urothelial cancer. Locally advanced urothelial cancer (UC), variably defined as muscle-invasive UC with a large or ...

Neoadjuvant treatment with disitamab vedotin plus perioperative toripalimab in patients with muscle-invasive bladder cancer (MIBC) with HER2 expression: Updated efficacy and safety results from the ...

Certain healthcare conditions often go unspoken, leading to silent struggles that affect the lives of many. Overactive bladder (OAB) and fecal incontinence (FI) are two such conditions, impacting ...

Although cisplatin is not recommended for patients with renal impairment, studies have been performed using cisplatin at lower or split doses. These studies indicate that administration of low-dose ...